Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon and Octreotide in Zollinger-Ellison Syndrome and Metastatic Gastrinoma
NCT00001228Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Oct 1988
- Modality
- Cytokines & Interferons, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa, octreotide in Zollinger–Ellison syndrome (ZES), gastrinoma, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Oct 1988; status: completed.
02
Drugs
interferon alfaoctreotide
03
Conditions
Zollinger–Ellison syndrome (ZES)gastrinoma
Beyond the preview
Go deeper on NCT00001228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001228.